HOME >> MEDICINE >> NEWS
Antibiotics within 4 hours of arrival at hospital better for pneumonia patients

CHICAGO Giving older patients antibiotics within four hours of their arrival at a hospital for treatment of pneumonia reduces the length of hospital stay, and may reduce the chances of dying, according to an article in the March 22 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

According to the article, pneumonia is the second leading reason for hospitalization among Medicare beneficiaries, accounting for more than 600,000 Medicare hospitalizations yearly, and is the fifth leading cause of death among Americans older than 65 years. Timely administration of antibiotics to hospitalized patients with pneumonia has been associated with improved survival, the article states. Guidelines recommend antibiotic treatment within eight hours of arrival at a hospital.

Peter M. Houck, M.D., from the Centers for Medicare & Medicaid Services, Seattle, and colleagues investigated whether administration of antibiotics within less than eight hours of arrival at the hospital was associated with significant improvements in hospitalized patients with pneumonia who had not been treated prior to arriving at the hospital.

The researchers examined medical records from a national random sample of 18,209 Medicare patients older than 65 years who were hospitalized with pneumonia from July 1998 through March 1999.

Among the 13,771 (75.6 percent) of patients who did not receive any treatment prior to their arrival at a hospital, antibiotic administration within four hours of arrival was associated with reduced death in the hospital (6.8 percent vs. 7.4 percent), reduced likelihood of dying within 30 days of admission to the hospital (11.6 percent vs. 12.7 percent) and reduced likelihood that the length of stay (LOS) at the hospital exceeded 5 days (42.1 percent vs. 45.1 percent). The average length of stay was an average of about half a day shorter for patients who received antibiotics within four hours of arriving at the
'"/>

Contact: Centers for Medicare & Medicaid Services
202-690-6145
JAMA and Archives Journals
22-Mar-2004


Page: 1 2

Related medicine news :

1. Antibiotics protect nerves in mice by turning on genes
2. Antibiotics not always beneficial for childhood ear infections
3. Antibiotics help heart patients
4. Antibiotics Reduce Inflammation In Heart Disease But Effect On Heart Attacks Remains Unproven
5. Understanding Why Antibiotics May Be Over-prescribed For Patients With Sore Throats
6. Researchers Synthesize Compounds For New Class Of Antibiotics
7. Physicists find patterns within seemingly random events of physiological systems
8. Scientists discover enzyme crucial to the transportation of proteins within cells
9. Non-drug treatment device delivers sustained blood pressure reductions within 3-4 weeks in the home
10. Bone cells help call the shots for the bloods stem cells within
11. Evaluation needed to gauge silent threat lurking within stroke patients

Post Your Comments:
(Date:10/25/2014)... Background: , In 1998 Bob Savage founded ... pioneer in the field of establishing recovery community organizations. ... and when he retired, he set out to answer a ... , 1. Where are the people in ... , 2. Can the recovery community be organized to advocate ...
(Date:10/25/2014)... 2014 Market Research Report ... 2009-2019 is a professional and in-depth market ... industry. The report firstly reviews the basic ... application and manufacturing technology. The report then ... Molecular Diagnostics listing their product specification, capacity, ...
(Date:10/25/2014)... October 25, 2014 The federal ... http://www.vaginalmeshlawsuit2015.com/ ) filed against Boston Scientific Corp. ... District Court, Southern District of West Virginia has ... Punitive Damages in a group of cases filed ... issued on October 21st, U.S. District Judge Joseph ...
(Date:10/25/2014)... blood supply to an arm or a leg before heart ... according to a new study. "During heart surgery ... to be able to operate on it. After some time ... produce energy because it doesn,t get oxygen. When we shut ... an arm or a leg, the body prepares for an ...
(Date:10/25/2014)... 2014 (HealthDay News) -- Researchers who discovered antibiotics ... are cause for concern. The use of ... for human consumption contribute to the development of ... background information from the study. Each year ... 2 million people and kill about 23,000, according ...
Breaking Medicine News(10 mins):Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Brief Interruption of Blood Supply to Limb Might Aid Heart Surgery: Study 2Health News:Researchers Say Antibiotics in Fish a Health Concern 2
(Date:10/22/2014)... 2014  Charlene Vernak, RPh, of Vernak Farms Pharmacy ... was awarded the George Roentsch Scholarship by the Professional ... in Houston during PCCA,s International ... annually to an independent pharmacist and PCCA member who ... Roentsch , a well-known pharmacist in the compounding community. ...
(Date:10/22/2014)... DIEGO , Oct. 22, 2014 AVACEN ... medical device received 510 (k) OTC clearance by the ... AVACEN 100 to be marketed over the Internet for: ... arthritis; muscle spasms; and minor strains and sprains . ... The AVACEN 100 (MSRP $2495) is a sophisticated ...
(Date:10/22/2014)... , October 22, 2014 ... ), a clinical-stage pharmaceutical company focused on the ... positive top-line clinical results from its Phase IIa ... insulin capsules, to treat type 1 diabetes. The trial ... under a U.S. Food and Drug ...
Breaking Medicine Technology:PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4
Cached News: